User profiles for Stephanie J. Lee
Stephanie J LeeFred Hutchinson Cancer Research Center Verified email at fhcrc.org Cited by 62722 |
[PDF][PDF] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
…, JJ Clark, S Moore, J Adelsperger, S Koo, JC Lee… - Cancer cell, 2005 - cell.com
Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with
myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors. An internet-…
myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors. An internet-…
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working …
This consensus document is intended to serve 3 functions. First, it standardizes the criteria
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical …
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical …
[HTML][HTML] National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and …
…, RS Wu, CS Cutler, GB Vogelsang, SJ Lee… - Biology of Blood and …, 2015 - Elsevier
The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …
[HTML][HTML] MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Y Pikman, BH Lee, T Mercher, E McDowell… - PLoS …, 2006 - journals.plos.org
Background The JAK2V617F allele has recently been identified in patients with polycythemia
vera (PV), essential thrombocytosis (ET), and myelofibrosis with myeloid metaplasia (MF). …
vera (PV), essential thrombocytosis (ET), and myelofibrosis with myeloid metaplasia (MF). …
[PDF][PDF] American Society of Clinical Oncology recommendations on fertility preservation in cancer patients
SJ Lee, LR Schover… - Journal of …, 2006 - allianceforfertilitypreservation.org
… Int J Radiat Oncol Biol Phys 62:738-744, 2005 … Tryde Schmidt KL, Yding Andersen C,
Starup J, et al: Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman …
Starup J, et al: Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman …
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
SJ Lee, J Klein, M Haagenson… - Blood, The Journal …, 2007 - ashpublications.org
The relative importance of various human leukocyte antigen (HLA) loci and the resolution
level at which they are matched has not been fully defined for unrelated donor transplantation. …
level at which they are matched has not been fully defined for unrelated donor transplantation. …
[HTML][HTML] Peripheral-blood stem cells versus bone marrow from unrelated donors
Background Randomized trials have shown that the transplantation of filgrastim-mobilized
peripheral-blood stem cells from HLA-identical siblings accelerates engraftment but increases …
peripheral-blood stem cells from HLA-identical siblings accelerates engraftment but increases …
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated …
CS Cutler, SJ Lee, P Greenberg, HJ Deeg, WS Pérez… - Blood, 2004 - ashpublications.org
Bone marrow transplantation (BMT) can cure myelodysplastic syndrome (MDS), although
transplantation carries significant risks of morbidity and mortality. Because the optimal timing of …
transplantation carries significant risks of morbidity and mortality. Because the optimal timing of …
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Risk factors for acute GVHD (AGVHD), overall survival, and transplant-related mortality were
evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from …
evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from …
[HTML][HTML] Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease
…, M Gowda, T Stefanelli, SJ Lee… - … England Journal of …, 2021 - Mass Medical Soc
Background Chronic graft-versus-host disease (GVHD), a major complication of allogeneic
stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in …
stem-cell transplantation, becomes glucocorticoid-refractory or glucocorticoid-dependent in …